Leslie Smith, DNP, shares how nurses at any hospital can work around limited time, heavy workloads, and slow approvals to get involved in research.
|Podcasts|September 3, 2021
- October 2021
- Volume 15
- Issue 5
Navigating Medical Cannabis in Cancer Care
Author(s)Lindsay Fischer
Over half of the states in the United States have legalized medical cannabis. What does that mean for nurses who care for patients with cancer?
Advertisement
For this episode, we spoke with Eloise Theisen, RN, MSN, AGPCNP-BC, current president of the American Cannabis Nurses Association (ACNA). She spoke to us about some the benefits and applications of medical cannabis for patients with cancer, some of the challenges and interesting updates in medical cannabis research, and how nurses can talk to their patients about cannabis, as well as monitor their patients for potential cannabis-related adverse events.
Articles in this issue
about 5 years ago
Applying Positive Psychology to Financial Planningabout 5 years ago
Continuing Education: October 2021about 5 years ago
Should the Oncology Nurse Get Vaccinated?about 5 years ago
Health Literacy Is Positively Associated With Medication Adherenceabout 5 years ago
Fall Into Better Health and Financial Practicesabout 5 years ago
Nurses Can Minimize Fear, Anxiety in Pediatric Patients With CancerAdvertisement
Related to this article
Leslie Smith, DNP, discusses mediating trial care, vetting protocols for nursing scope of practice, and guiding frontline nurses toward research.
Nicole Doell, MSN, RN, of Sylvester explains how nurses can address breast cancer misinformation without judgment and share vetted resources.
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Sylvester's Nicole Doell, MSN, RN, discusses how oncology nurses can support patients with breast cancer emotionally, from diagnosis to survivorship.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Daraxonrasib, tarlatamab, an mRNA melanoma therapy and ivonescimab led ESMO 2026. Tell us which findings you can act on now.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses
2
What Nurses Should Tell Patients About Vitamin C in CCUS and MDS
3
How Oncology Nurses Can Overcome Common Barriers to Research
4
Vicarious Trauma Affects Oncology Nurses in Every Care Setting
5